Chunghwa Chemical Synthesis & Biotech Management
Management criteria checks 2/4
Chunghwa Chemical Synthesis & Biotech's CEO is Chung-Hsin Huang, appointed in Apr 2018, has a tenure of 6.75 years. directly owns 0.067% of the company’s shares, worth NT$1.72M. The average tenure of the management team and the board of directors is 6.8 years and 5 years respectively.
Key information
Chung-Hsin Huang
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 6.8yrs |
| CEO ownership | 0.07% |
| Management average tenure | 6.8yrs |
| Board average tenure | 5yrs |
Recent management updates
Recent updates
Why Chunghwa Chemical Synthesis & Biotech's (TWSE:1762) Shaky Earnings Are Just The Beginning Of Its Problems
Nov 22
Chunghwa Chemical Synthesis & Biotech (TWSE:1762) Has A Somewhat Strained Balance Sheet
Nov 14Chunghwa Chemical Synthesis & Biotech Co., Ltd.'s (TWSE:1762) Business And Shares Still Trailing The Industry
Aug 09Chunghwa Chemical Synthesis & Biotech's (TWSE:1762) Dividend Is Being Reduced To NT$0.80
Jul 12Chunghwa Chemical Synthesis & Biotech's (TWSE:1762) Sluggish Earnings Might Be Just The Beginning Of Its Problems
Apr 04A Look At The Intrinsic Value Of Chunghwa Chemical Synthesis & Biotech Co., Ltd. (TPE:1762)
Apr 01Chunghwa Chemical Synthesis & Biotech Co., Ltd.'s (TPE:1762) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Mar 04What To Know Before Buying Chunghwa Chemical Synthesis & Biotech Co., Ltd. (TPE:1762) For Its Dividend
Jan 28Should You Rely On Chunghwa Chemical Synthesis & Biotech's (TPE:1762) Earnings Growth?
Jan 02The Chunghwa Chemical Synthesis & Biotech (TPE:1762) Share Price Is Up 131% And Shareholders Are Boasting About It
Dec 06CEO
Chung-Hsin Huang
6.8yrs
Tenure
Mr. Chung-Hsin Huang serves as President & General Manager at Chunghwa Chemical Synthesis & Biotech Co., Ltd. Since April 1, 2018 and served as Director until May 2022. Mr. Huang had been Vice President of...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President & GM | 6.8yrs | no data | 0.067% NT$ 1.7m | |
| Manager of Finance Department & Head of Corporate Governance | 6.2yrs | no data | no data | |
| Manager of Human Resource Office | 6.9yrs | no data | no data | |
| Chief Auditor | no data | no data | no data |
6.8yrs
Average Tenure
Experienced Management: 1762's management team is seasoned and experienced (6.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Director | 14.6yrs | no data | no data | |
| Independent Director | 8.7yrs | no data | no data | |
| Director | 5yrs | no data | 1.3% NT$ 33.4m | |
| Chairman of the Board | 4.2yrs | no data | 3.17% NT$ 81.6m | |
| Vice-Chairman | less than a year | no data | no data |
5.0yrs
Average Tenure
Experienced Board: 1762's board of directors are considered experienced (5 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/10 03:34 |
| End of Day Share Price | 2025/01/10 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Chunghwa Chemical Synthesis & Biotech Co., Ltd. is covered by 9 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yenya Kuo | Capital Securities Corporation |
| Ryan Liu | IBTS Investment Consulting Co., Ltd. |
| Zhennan Lee | Jih Sun Securities Investment Consulting Co., Ltd. |